Skip to main content
HR 3155 108th Congress House Taxation Commerce Consumer education Costs Deceptive advertising Drug advertising Drug industry Drugs Government Operations and Politics Government paperwork Health Income tax Tax deductions

Fair Balance Prescription Drug Advertisement Act of 2003

Introduced: September 23, 2003 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 6, 2003
Referred to the Subcommittee on Health.
Sep 23, 2003
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 23, 2003
Sponsor introductory remarks on measure. (CR E1862-1863)
Sep 23, 2003
Introduced in House
 Plain-English summary Congressional Research Service
Fair Balance Prescription Drug Advertisement Act of 2003 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.
What's happening now October 6, 2003

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3